CLINICAL OUTCOME OF AN PROSPECTIVE, MULTICENTRE, RANDOMIZED, PHASE III NON‐INFERIORITY CLINICAL TRIAL FOR PATIENTS WITH EXTRANODAL NK/T CELL LYMPHOMA TREATED BY P‐GEMOX OR AspaMetDex. (12th June 2019) - Huang, H.; Gao, Y.; Su, H.; Huang, Y.; Gao, Y.; Wang, X.; Bai, B.; Zhang, Y.; Su, L.; Chu, X.; Li, W.; Zhang, J.; et al.